+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Wound Care Market Size, Share & Trends Analysis Report by Product (Advanced Wound Dressing, Surgical Wound Care, Traditional Wound Care), Application, End-use, Mode Of Purchase, Distribution Channel, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 176 Pages
  • December 2023
  • Region: United States
  • Grand View Research
  • ID: 5921076
The U.S. wound care market size is anticipated to reach USD 11.42 billion by 2030. The market is expected to grow at a CAGR of 4.11% from 2024 to 2030. An increase in number of accidents, rising geriatric population, increasing number of ambulatory surgical centers (ASCs). Also, rapid advancements in healthcare technology are key contributors to the market growth.

The prevalence of chronic disorders that affect skin integrity, such as diabetes and peripheral vascular disease (venous hypertension, arterial insufficiency), is growing with the rising geriatric population. Skin breakdown, ulceration, and the formation of chronic sores are common results of these diseases. Furthermore, the elderly have a weakened immune system and a higher risk of infection, which makes wound treatment more difficult for them. This increases the need for sophisticated wound care solutions, particularly in cases of severe wounds. Thereby boosting the need for advanced wound care products. For instance, in May 2023, according to the United Health Foundation, more than 55.8 million adults ages 65 and older live in the U.S., accounting for about 16.8% of the nation's population. These factors are expected to boost the market growth over the forecast period.

The increasing prevalence of chronic diseases is a major factor driving the market growth in the U.S. Antimicrobial resistance, unhealthy and sedentary lifestyles, and alcohol and tobacco use are some of the factors that are causing the prevalence of non-communicable diseases to rise. For instance, in December 2022, the CDC estimated that 6 in 10 adults in the U.S. currently live with a chronic disease such as cancer, heart disease, or diabetes. Moreover, according to the National Association of Chronic Disease Directors, 2022, nearly 60% of adult Americans have at least one chronic disease. These above-mentioned factors are expected to propel the market growth over the forecast period.

U.S. Wound Care Market Report Highlights

  • Based on the product, the advanced wound dressing segment dominated the market in 2023 with the largest share owing to the increasing cases of diabetes.
  • Based on application, the chronic wounds segment dominated the market in 2023 with the highest share owing to an increasing incidence of diabetes and diabetic foot ulcers.
  • The hospital's segment held the largest share of the overall end-use market in 2023 owing to the growing incidence of chronic wounds, an increase in the number of surgeries, and a rise in the aging population.
  • Based on mode of purchase, the prescribed segment dominated the market in 2023 with the highest share because as per Health Policy Institute, around 66% of the U.S. consumes prescription medicines.
  • Based on distribution channel, the institutional sales segment dominated the market in 2023 with the highest share owing to as majority of the products for advanced wound care are directly distributed across various settings, such as hospitals & other healthcare facilities.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Mode of purchase
1.1.5. Distribution channel
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia-Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Mode of purchase outlook
2.2.5. Distribution channel outlook
2.3. Competitive Insights
Chapter 3. U.S. Wound Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.2.1.2. Introduction of innovative and advanced wound products
3.2.1.3. Rising geriatric population
3.2.1.4. Increasing number of ambulatory surgical centers (ASCs)
3.2.1.5. Increasing number of accidents
3.2.1.6. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions
3.2.1.7. Improvements in public and private hospital infrastructure
3.2.2. Market restraint analysis
3.2.2.1. Stringent manufacturing policies
3.2.2.2. High cost of advanced wound care products and chronic wound treatments
3.2.3. Market opportunity analysis
3.3. U.S. Wound Care Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. U.S. Wound Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Advanced wound dressing
4.1.2. Surgical wound care
4.1.3. Traditional wound care
4.1.4. Wound therapy devices
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. U.S. Wound Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Advanced wound dressing
4.5.1.1. Advanced wound dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. Foam dressings
4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Hydrocolloid dressings
4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.4. Film dressings
4.5.1.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.5. Alginate dressings
4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.6. Hydrogel dressings
4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.7. Collagen dressings
4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.8. Other advanced dressings
4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Surgical wound care
4.5.2.1. Surgical wound care market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.2. Sutures & staples
4.5.2.2.1. Sutures & staples market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.3. Tissue adhesives & sealants
4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2018 to 2030 (USD Million)
4.5.2.4. Anti-infective dressing
4.5.2.4.1. Anti-infective dressing market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Traditional wound care
4.5.3.1. Traditional wound care market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.2. Medical tapes
4.5.3.2.1. Medical tapes market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.3. Cotton
4.5.3.3.1. Cotton market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.4. Bandages
4.5.3.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.5. Gauzes
4.5.3.5.1. Gauzes market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.6. Sponges
4.5.3.6.1. Sponges market estimates and forecast 2018 to 2030 (USD Million)
4.5.3.7. Cleansing agents
4.5.3.7.1. Cleansing agents market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Wound therapy devices
4.5.4.1. Wound therapy devices market estimates and forecast 2018 to 2030s, (USD Million)
4.5.4.2. Negative pressure wound therapy
4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.3. Oxygen and hyperbaric oxygen equipment
4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.4. Electric stimulation devices
4.5.4.4.1. Electric stimulation devices market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.5. Pressure relief devices
4.5.4.5.1. Pressure relief devices market estimates and forecast 2018 to 2030 (USD Million)
4.5.4.6. Others
4.5.4.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.S. Wound Care Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Acute Wounds
5.1.2. Chronic Wounds
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. U.S. Wound Care Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Acute Wounds
5.5.1.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.2. Surgical & traumatic wounds
5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.1.3. Burns
5.5.1.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Chronic Wounds
5.5.2.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.2. Diabetic foot ulcers
5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.3. Pressure ulcers
5.5.2.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.4. Venous leg ulcers
5.5.2.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
5.5.2.5. Others chronic wounds
5.5.2.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. U.S. Wound Care Devices: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Outpatient facilities
6.1.3. Home care
6.1.4. Research & manufacturing
6.2. End Use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. U.S. Wound Care Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Outpatient facilities
6.5.2.1. Outpatient facilities centers market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Home care
6.5.3.1. Home care market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Research & manufacturing
6.5.4.1. Research & manufacturing market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. U.S. Wound Care Devices: Mode of Purchase Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Prescribed
7.1.2. Non-prescribed (OTC)
7.2. Mode of Purchase Market Share, 2018 & 2030
7.3. Segment Dashboard
7.4. U.S. Wound Care Market by Mode of Purchase Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Prescribed
7.5.1.1. Prescribed market estimates and forecast 2018 to 2030 (USD Million)
7.5.2. Non-prescribed (OTC)
7.5.2.1. Non-prescribed (OTC) market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. U.S. Wound Care Devices: Distribution Channel Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Institutional sales
8.1.2. Retail sales
8.2. Distribution Channel Market Share, 2018 & 2030
8.3. Segment Dashboard
8.4. U.S. Wound Care Market by Distribution Channel Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. Institutional sales
8.5.1.1. Institutional sales market estimates and forecast 2018 to 2030 (USD Million)
8.5.2. Retail sales
8.5.2.1. Retail sales market estimates and forecast 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Smith & Nephew PLC
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Mölnlycke Health Care AB
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. ConvaTec Group PLC
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Baxter International
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. URGO Medical
9.3.8.1. Financial performance
9.3.8.2. Product benchmarking
9.3.8.3. Strategic initiatives
9.3.9. Coloplast Corp.
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Medtronic
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. 3M
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Derma Sciences (Integra LifeSciences)
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Medline Industries, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
9.3.14. 3M
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Product benchmarking
9.3.14.4. Strategic initiatives
9.3.15. Ethicon (Johnson & Johnson)
9.3.15.1. Company overview
9.3.15.2. Financial performance
9.3.15.3. Product benchmarking
9.3.15.4. Strategic initiatives
9.3.16. B. Braun SE
9.3.16.1. Company overview
9.3.16.2. Financial performance
9.3.16.3. Product benchmarking
9.3.16.4. Strategic initiatives
9.3.17. Cardinal Health, Inc.
9.3.17.1. Company overview
9.3.17.2. Financial performance
9.3.17.3. Product benchmarking
9.3.17.4. Strategic initiatives
9.3.18. Organogenesis Inc
9.3.18.1. Company overview
9.3.18.2. Financial performance
9.3.18.3. Product benchmarking
9.3.18.4. Strategic initiatives
9.3.19. MIMEDX Group, Inc.
9.3.19.1. Company overview
9.3.19.2. Financial performance
9.3.19.3. Product benchmarking
9.3.19.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 US wound care market, by product, 2018-2030 (USD Million)
Table 4 US wound care, by application, 2018-2030 (USD Million)
Table 5 US wound care market, by end-use, 2018-2030 (USD Million)
Table 6 US wound care market, by mode of purchase, 2018-2030 (USD Million)
Table 7 US wound care market, by distribution channel, 2018-2030 (USD Million)
List of Figures
Figure 1 US Wound Care Market Segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market outlook (2023)
Figure 10 Segment Outlook
Figure 11 Strategy framework
Figure 12 Penetration & growth prospect mapping
Figure 13 Consumer behavior analysis
Figure 14 Market driver relevance analysis (Current & future impact)
Figure 15 Market restraint relevance analysis (Current & future impact)
Figure 16 Market opportunities relevance analysis (Current & future impact)
Figure 17 Porter’s five forces analysis
Figure 18 PESTLE (political & legal, economic and technological) analysis
Figure 19 US wound care market: product movement analysis
Figure 20 Segment dashboard
Figure 21 US wound care market product outlook: Key takeaways
Figure 22 Advanced wound dressing market, 2018-2030 (USD Million)
Figure 23 Foam dressings market, 2018-2030 (USD Million)
Figure 24 Hydrocolloid dressings market, 2018-2030 (USD Million)
Figure 25 Film dressings market, 2018-2030 (USD Million)
Figure 26 Alginate dressings market, 2018-2030 (USD Million)
Figure 27 Hydrogel dressings market, 2018-2030 (USD Million)
Figure 28 Collagen dressings market, 2018-2030 (USD Million)
Figure 29 Other advanced dressings market, 2018-2030 (USD Million)
Figure 30 Surgical wound care market, 2018-2030 (USD Million)
Figure 31 Sutures & staples market, 2018-2030 (USD Million)
Figure 32 Tissue adhesives and sealants market, 2018-2030 (USD Million)
Figure 33 Anti-infective dressing market, 2018-2030 (USD Million)
Figure 34 Traditional wound care market, 2018-2030 (USD Million)
Figure 35 Medical tapes market, 2018-2030 (USD Million)
Figure 36 Cotton market, 2018-2030 (USD Million)
Figure 37 Bandages market, 2018-2030 (USD Million)
Figure 38 Gauzes market, 2018-2030 (USD Million)
Figure 39 Sponges market, 2018-2030 (USD Million)
Figure 40 Cleansing agents market, 2018-2030 (USD Million)
Figure 41 Wound therapy devices market, 2018-2030 (USD Million)
Figure 42 Negative pressure wound therapy market, 2018-2030 (USD Million)
Figure 43 Oxygen and hyperbaric oxygen equipment market, 2018-2030 (USD Million)
Figure 44 Electric stimulation devices market, 2018-2030 (USD Million)
Figure 45 Pressure relief devices market, 2018-2030 (USD Million)
Figure 46 Others market, 2018-2030 (USD Million)
Figure 47 US wound care market: end-use movement analysis
Figure 48 Segment dashboard
Figure 49 US wound care market End-use outlook: Key takeaways
Figure 50 Hospitals market, 2018-2030 (USD Million)
Figure 51 Outpatient facilities market, 2018-2030 (USD Million)
Figure 52 Home care market, 2018-2030 (USD Million)
Figure 53 Research & manufacturing market, 2018-2030 (USD Million)
Figure 54 US wound care market: Application movement analysis
Figure 55 Segment dashboard
Figure 56 US wound care market application outlook: Key takeaways
Figure 57 Acute wounds market, 2018-2030 (USD Million)
Figure 58 Surgical & traumatic wounds market, 2018-2030 (USD Million)
Figure 59 Burns market, 2018-2030 (USD Million)
Figure 60 Chronic wounds market, 2018-2030 (USD Million)
Figure 61 Diabetic foot ulcers market, 2018-2030 (USD Million)
Figure 62 Pressure ulcers market, 2018-2030 (USD Million)
Figure 63 Venous leg ulcers market, 2018-2030 (USD Million)
Figure 64 Others chronic wounds market, 2018-2030 (USD Million)
Figure 65 US wound care market: Mode of purchase movement analysis
Figure 66 Segment dashboard
Figure 67 US wound care market mode of purchase outlook: Key takeaways
Figure 68 Prescribed market, 2018-2030 (USD Million)
Figure 69 Non-prescribed (OTC) market, 2018-2030 (USD Million)
Figure 70 US wound care market: Distribution channel movement analysis
Figure 71 Segment dashboard
Figure 72 US wound care market distribution channel outlook: Key takeaways
Figure 73 Institutional sales market, 2018-2030 (USD Million)
Figure 74 Retail sales market, 2018-2030 (USD Million)
Figure 75 Ansoff Matrix
Figure 76 Regional network map

Companies Mentioned

  • Smith & Nephew PLC
  • Mölnlycke Health Care AB
  • ConvaTec Group PLC
  • Baxter International
  • URGO Medical
  • Coloplast Corp.
  • Medtronic
  • 3M
  • Derma Sciences (Integra LifeSciences)
  • Medline Industries, Inc.
  • 3M
  • Ethicon (Johnson & Johnson)
  • B. Braun SE
  • Cardinal Health, Inc.
  • Organogenesis Inc
  • MIMEDX Group, Inc.

Methodology

Loading
LOADING...

Table Information